Institutional Ownership Galectin Therapeutics Inc (GALT)
This table provides information about the institutional ownership of Galectin Therapeutics Inc (GALT). We have compiled data on the 93 institutions that hold shares in the stock, with a total of 9.97 Million shares, which have been reported (via 13F filing form) to have a value of $12.4 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
Omaha, NE |
Jan 17, 2025 Q4 2024 |
600
shares
|
$744
0.0% of portfolio
|
Q2 2024
New holding
|
|
Global Retirement Partners, LLC
|
Jan 31, 2025 Q4 2024 |
250
shares
|
$310
0.0% of portfolio
|
Q2 2023
Reduced 28.57%
|
|
Cwm, LLC
|
Oct 08, 2024 Q3 2024 |
170
shares
|
$210
0.0% of portfolio
|
Q3 2024
New holding
|
|
Salem Investment Counselors Inc
Winston Salem, NC |
Jan 13, 2025 Q4 2024 |
167
shares
|
$207
0.0% of portfolio
|
Q2 2019
New holding
|
|
Sterling Capital Management LLC
Charlotte, NC |
Nov 12, 2024 Q3 2024 |
38
shares
|
$47
0.0% of portfolio
|
Q3 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|